Sp210

THERAPEUTIC POTENTIAL OF MICROBIOTA DERIVED AHR LIGANDS IN IBD

Date
May 6, 2023
Explore related products in the following collection:

Society: AGA

The role of nutrition and the microbiome is evident in IBD and functional bowel disorders. The microbiome can affect the way nutrients are metabolized in bioactive components. It is of important to understand the molecular sensors of such metabolized components. Tryptophan is known to mediate Indole derivatives and other molecules that activate a nuclear receptor Aryl Hydrocarbon Receptor. Recently, many advances were made in relating tryptophan and its metabolites to a variety of inflammatory and functional disorders. The session brings together specialists in the field that work on AhR signaling in IBD, IBS, Celiac disease and cancer, to review current strategies to understand tryptophan metabolites and potentially harness nutritional support of disease states.

Tracks

Related Products

Thumbnail for ABNORMAL BILE ACID PROFILES CONTRIBUTE TO COLITIS INDUCED BY AN AGGRESSIVE SUBSET OF HEALTHY HUMAN BACTERIA
ABNORMAL BILE ACID PROFILES CONTRIBUTE TO COLITIS INDUCED BY AN AGGRESSIVE SUBSET OF HEALTHY HUMAN BACTERIA
BACKGROUND: Emerging evidence suggest that gut microbiota influence human health such as digestive functions and risk of sepsis…
Thumbnail for MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for INTRODUCTION
INTRODUCTION
SOCIETY: AGA
Thumbnail for HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…